On September 13, 2003, the Spanish medical journal Medicina Clínica published Jose Carlos Bouso’s letter to the editor (PDF, page 3) entitled “MDMA (‘ecstasy’) psychotherapy …
For the last several months, another independent Institutional Review Board (IRB) has been reviewing Dr. Michael Mithoefer’s MAPS -sponsored MDMA/PTSD protocol. Today, we submitted our response to …
Greetings, MAPS members! This is the third edition of the MAPS news email update. We’re happy to report several items of progress in both research projects and in our efforts at outreach and education. …
Happy Summer, MAPS members! This is the second edition of our newly-created email update for members. We have several items of encouraging news to report: In medical marijuana news: Grant awarded for vaporizer …
Drs. Mithoefer, Jerome and Doblin have written a reply to the Ricaurte et al. letter published in Science on June 6, 2003. We have submitted our reply to Drs. Ricaurte and McCann and indicated that we …
On May 28, 2003, José Carlos Bouso, PhD, learned that a Letter to the Editor that he wrote to the Spanish Medical Journal Medicina Clínica (Clinical Medicine), was accepted for publication. The …
Greetings, MAPS members! We hope you’re enjoying the Spring 2003 MAPS bulletin! If you haven’t received your copy, let us know. (International members will have to wait a bit longer.) In an …
Tripping De-Light Fantastic Are psychedelic drugs good for you? By John Horgan Slate Magazine A year ago, hoping to dispel the postpartum gloom that had gripped me after I finished writing a book, I hiked …
On April 28, 2003, a lengthy article in the prominent Spanish magazine Interviu reported on the controversy surrounding the Spanish MDMA/PTSD study and brought to light the fact that the Madrid Anti-Drug …
Download this entire issue or browse individual articles by title below. Front Cover Back Cover Front Cover Table of Contents 3 Letter from Rick Doblin, MAPS President Rick Doblin, Ph.D. 4 MDMA-Assisted …
The new IRB informed MAPS today that it has decided not to accept the protocol for review. MAPS was clearly told in writing a month ago that this IRB would accept the protocol for review. Now, after we …
A new IRB has reviewed the documents from the first two IRBs that led to dead-ends and agreed to review the protocol. Documents were submitted, with feedback expected in a month or so.